{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:09:26Z","timestamp":1757704166601},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ahjonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ahj.2016.01.014","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T17:45:35Z","timestamp":1453743935000},"page":"9-18","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study"],"prefix":"10.1016","volume":"178","clinical-trial-number":[{"clinical-trial-number":"nct02430012","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Chenfei","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhe","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengshou","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ahj.2016.01.014_bb0005","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.athoracsur.2006.10.046","article-title":"Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery","volume":"83","author":"Goyal","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.ahj.2016.01.014_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ahj.2016.01.014_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ahj.2016.01.014_bb0020","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/CIRCULATIONAHA.114.014209","article-title":"Efficacy of Long-Term beta-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery","volume":"131","author":"Zhang","year":"2015","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ahj.2016.01.014_bb0025","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Aspirin and mortality from coronary bypass surgery","volume":"347","author":"Mangano","year":"2002","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ahj.2016.01.014_bb0030","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.114.013042","volume":"131","author":"Iqbal","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ahj.2016.01.014_bb0035","first-page":"646","article-title":"In-hospital initiation of cardiovascular protective medications for patients undergoing percutaneous coronary intervention: taking advantage of the teachable moment","volume":"15","author":"Fonarow","year":"2003","journal-title":"J Invasive Cardiol"},{"issue":"23","key":"10.1016\/j.ahj.2016.01.014_bb0040","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1161\/CIR.0b013e31823b5fee","article-title":"2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Hillis","year":"2011","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ahj.2016.01.014_bb0045","first-page":"e340","volume":"110","author":"Eagle","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ahj.2016.01.014_bb0050","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the american heart association","volume":"131","author":"Kulik","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2016.01.014_bb0055","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0735-1097(99)00389-7","volume":"34","author":"Eagle","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2016.01.014_bb0060","first-page":"267","article-title":"Cardiovascular Diseases Special Committed of Chinese Association of Rehabilitation Medicine, China CaCDSCoGSo. Rehabilitation and Secondary Prevention of Coronary Artery Disease: a Expert Consensus in China","volume":"41","author":"Chinese Society of Cardiology of Chinese Medical Association","year":"2013","journal-title":"Chin J Cardiol"},{"issue":"11 Suppl","key":"10.1016\/j.ahj.2016.01.014_bb0065","first-page":"I207","article-title":"Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database","volume":"116","author":"Hiratzka","year":"2007","journal-title":"Circulation"},{"issue":"8b","key":"10.1016\/j.ahj.2016.01.014_bb0070","doi-asserted-by":"crossref","first-page":"45h","DOI":"10.1016\/S0002-9149(97)00820-5","article-title":"The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient","volume":"80","author":"Pearson","year":"1997","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2016.01.014_bb0075","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ahj.2003.12.024","article-title":"Secondary prevention after coronary artery bypass graft: a primary issue?","volume":"147","author":"Ferguson","year":"2004","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2016.01.014_bb0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.110.981068","article-title":"Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice","volume":"123","author":"Williams","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2016.01.014_bb0085","doi-asserted-by":"crossref","first-page":"426.e1","DOI":"10.1016\/j.amjmed.2014.11.013","article-title":"Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease","volume":"128","author":"Kumbhani","year":"2015","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ahj.2016.01.014_bb0090","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0003-4975(02)04885-3","article-title":"Secondary prevention after coronary bypass: the American Heart Association \"Get with the Guidelines\" program","volume":"75","author":"Denton","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2016.01.014_bb0095","series-title":"Report On Cardiovascular Diseases In China (2012)","author":"Hu","year":"2013"},{"issue":"3","key":"10.1016\/j.ahj.2016.01.014_bb0100","first-page":"129","article-title":"White Paper On 2013 China Cardiar Surgery And Extracorporeal Circulation Data","volume":"2014","author":"Deming Zhu","year":"2014","journal-title":"Chin J Extracorporeal Circ"},{"issue":"4","key":"10.1016\/j.ahj.2016.01.014_bb0105","first-page":"236","article-title":"Medical therapy in revascularized coronary artery disease patients","volume":"88","author":"Liu","year":"2008","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"4","key":"10.1016\/j.ahj.2016.01.014_bb0110","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.athoracsur.2015.09.038","article-title":"The Chinese Cardiac Surgery Registry: Design and Data Audit","volume":"101","author":"Rao","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2016.01.014_bb0115","series-title":"Chinese Cardiovascular Surgery Regsitry Data Report 2013-2014","author":"Group","year":"2014"},{"issue":"6","key":"10.1016\/j.ahj.2016.01.014_bb0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijsu.2008.08.012","article-title":"Delivering surgical training in the People's Republic of China: are current mechanisms adequate?","volume":"6","author":"Wan","year":"2008","journal-title":"Int J Surg"},{"key":"10.1016\/j.ahj.2016.01.014_bb0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.12927\/cjnl.2013.23363","article-title":"Continuous quality improvement: a shared governance model that maximizes agent-specific knowledge","author":"Burkoski","year":"2013","journal-title":"Nurs Leadersh"},{"issue":"4","key":"10.1016\/j.ahj.2016.01.014_bb0130","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/1468-0009.00107","article-title":"Assessing the impact of continuous quality improvement on clinical practice: what it will take to accelerate progress","volume":"76","author":"Shortell","year":"1998","journal-title":"Milbank Q"},{"key":"10.1016\/j.ahj.2016.01.014_bb0135","series-title":"Smartphone Ownership-2013 Updata","author":"Center","year":"2013"},{"key":"10.1016\/j.ahj.2016.01.014_bb0140","series-title":"Report on the obile consumers in the Asia-Pacific region","author":"Nielsen","year":"2014"},{"issue":"6","key":"10.1016\/j.ahj.2016.01.014_bb0145","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCOUTCOMES.113.000441","article-title":"The China Patient-Centered Evaluative Assessment of Cardiac Events (China PEACE) Retrospective Study of Acute Myocardial Infarction: Study Design","volume":"6","author":"Dharmarajan","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.ahj.2016.01.014_bb0150","doi-asserted-by":"crossref","first-page":"e004595","DOI":"10.1136\/bmjopen-2013-004595","article-title":"Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) retrospective study of coronary catheterisation and percutaneous coronary intervention","volume":"4","author":"Li","year":"2014","journal-title":"BMJ Open"},{"issue":"23","key":"10.1016\/j.ahj.2016.01.014_bb0155","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","volume":"58","author":"Smith","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2016.01.014_bb0160","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2013.277064","article-title":"Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial","volume":"310","author":"Thom","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ahj.2016.01.014_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cct.2009.03.007","article-title":"Effect of imbalance and intracluster correlation coefficient in cluster randomization trials with binary outcomes when the available number of clusters is fixed in advance","volume":"30","author":"Ahn","year":"2009","journal-title":"Contemp Clin Trials"},{"issue":"9818","key":"10.1016\/j.ahj.2016.01.014_bb0170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)60278-5","article-title":"Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study","volume":"379","author":"Meng","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ahj.2016.01.014_bb0175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCOUTCOMES.111.962365","article-title":"Coronary Artery Bypass Graft: Contemporary Heart Surgery Center Performance in China","volume":"5","author":"Hu","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2016.01.014_bb0180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0140-6736(14)60921-1","article-title":"ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data","volume":"385","author":"Li","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ahj.2016.01.014_bb0185","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/STROKEAHA.110.604249","article-title":"Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR)","volume":"42","author":"Wang","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2016.01.014_bb0190","article-title":"Notification on Launching the Pilot of Clinical Pathway Management","author":"Ministry of Health of the People's Republic of China","year":"2009"},{"key":"10.1016\/j.ahj.2016.01.014_bb0195","article-title":"Notification on Management Practices Cardiovascular Interventional Diagnosis and Treatment Procedures","author":"National Health and Family Planning Commission of the People's Republic of China","year":"2007"},{"key":"10.1016\/j.ahj.2016.01.014_bb0200","article-title":"Quality Contron Indicators for Six Specific Diseases","author":"Medical Administration Department of the National Commission for Health and Family Planning of the People's Republic of China","year":"2008"},{"issue":"1","key":"10.1016\/j.ahj.2016.01.014_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ijcp.12582","article-title":"Does mHealth increase adherence to medication? Results of a systematic review","volume":"69","author":"Anglada-Martinez","year":"2015","journal-title":"Int J Clin Pract"},{"issue":"24","key":"10.1016\/j.ahj.2016.01.014_bb0210","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.jacc.2011.08.009","volume":"58","author":"Hillis","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2016.01.014_bb0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jama.291.2.195","article-title":"Procedural volume as a marker of quality for CABG surgery","volume":"291","author":"Peterson","year":"2004","journal-title":"JAMA"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T00:22:30Z","timestamp":1537057350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870316000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":43,"alternative-id":["S0002870316000302"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2016.01.014","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2016.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}